SLU-PP-332 – 5mg Research Peptide

SLU-PP-332 (5mg) — Research Compound

SLU-PP-332 is a small-molecule agonist of the Estrogen-Related Receptors (ERRs), specifically targeting ERRα, ERRβ, and ERRγ. These receptors are key regulators of metabolic gene expression related to mitochondrial biogenesis and oxidative metabolism. Researchers study SLU-PP-332 for its ability to mimic the metabolic effects of endurance exercise by upregulating genes that enhance fatty acid oxidation and glucose utilization in skeletal muscle.

Findings from early-stage clinical trials have reported:

• Increases in the expression of genes related to mitochondrial biogenesis observed in muscle tissue
  
• Improved treadmill running endurance of approximately 70% reported in experimental models
  
• Significant reductions in fat mass and the prevention of weight gain noted in research cohorts
  
• Enhancements in oxidative capacity and glucose uptake reported in skeletal muscle cell cultures
  

Researchers utilize SLU-PP-332 to investigate the potential for “exercise mimetics” in managing metabolic dysregulation. By focusing on the ERR signaling pathway, it serves as a unique tool for studying the biological response to simulated physical activity and the subsequent impact on systemic lipid metabolism. This compound is a primary focus for research into the management of metabolic syndrome and the preservation of muscle function during inactivity.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use